Close

Amgen (AMGN), UCB Announce FDA Acceptance of BLA For Romosozumab

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. NFLX
2. INFY
3. ISRG
4. SPY
5. JWN
6. TSM
7. BZUN
8. ELV
9. AXP
10. SLB


Go back to Amgen (AMGN), UCB Announce FDA Acceptance of BLA For Romosozumab
Amgen Inc (NASDAQ: AMGN) Delayed: 262.75 --0 (-0%)
Previous Close $262.75    52 Week High $176.85 
Open $262.75    52 Week Low $133.64 
Day High $262.75    P/E 39.57 
Day Low $262.75    EPS $6.64 
Volume 227       

UCB Unsponsored ADR (AMEX: UCBJY) Delayed: 63.68 --0 (-0%)
Previous Close $63.68    52 Week High $46.25 
Open $63.68    52 Week Low $32.74 
Day High $63.68    P/E N/A 
Day Low $63.68    EPS $0.00 
Volume 1